Patents by Inventor Takeshi MINAMIDA

Takeshi MINAMIDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11541104
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: January 3, 2023
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi Minamida, Ryo Kato, Akira Koike, Atsushi Ose, Akihiro Kitami, Takashi Makiyama, Hikaru Yamamoto, Kazuhiko Kitagawa, Ryoko Takao
  • Publication number: 20210260166
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 26, 2021
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi MINAMIDA, Ryo KATO, Akira KOIKE, Atsushi OSE, Akihiro KITAMI, Takashi MAKIYAMA, Hikaru YAMAMOTO, Kazuhiko KITAGAWA, Ryoko TAKAO
  • Publication number: 20210077590
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi MINAMIDA, Ryo KATO, Akira KOIKE, Atsushi OSE, Akihiro KITAMI, Takashi MAKIYAMA, Hikaru YAMAMOTO, Kazuhiko KITAGAWA, Ryoko TAKAO